Summary
- Current Price
- As of today, ATNM price is $1.47, down -3.92% on
- Current Price All-Time High
- ATNM price is currently -99.67% below its historical high of $450.00 set on
- Market Cap
- ATNM current market cap is $46M, up +4.34% over the past 365 days
- PE Ratio
- ATNM current PE ratio is 4.12
- Revenue
- ATNM current annual revenue is $90.00K, up +100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for ATNM has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Actinium Pharmaceuticals, Inc. |
| Ticker | NYSEAmerican: ATNM |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | actiniumpharma.com |
| Employees | 31 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.47 | ||
| Price, 1D Change | -3.92% | |
| $46M | ||
| - | ||
| 4.12 | ||
| 0.44 | ||
| $90.00K | ||
| Revenue, 1Y Change | +100.00% | |
| -$1.09 | ||
| EPS, 1Y Change | +14.59% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:30 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.09 | ||
| EPS Estimate | $0.14 | N/A |
| EPS Est. Change | +112.89% | N/A |
| $90.00K | ||
| Revenue Estimate | $17.50M | N/A |
| Revenue Est. Change | +19,344.44% | N/A |
| $1.47 | ||
| Price Target | $4.00 | - |
| Price Tgt. Change | +172.11% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.43 | -$1.27 | +10.75% | |
| -$1.08 | -$1.09 | -0.58% | |
| $0.14 | N/A | +112.89% | |
| -$0.53 | N/A | +51.67% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $92.50K | $90.00K | -2.70% | |
| $17.50M | N/A | +19,344.44% | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +3.52% | ||
| -73.61% | ||
| +4.34% | ||
| -69.73% | ||
| +100.00% | ||
| -90.32% | ||
| +14.59% | ||
| +20.57% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.47 | ||
| $1.12 | ||
| $1.19 | ||
| $1.19 | ||
| $1.21 | ||
| $0.09 | ||
| 0.44 | ||
| $0.12 | ||
| 60.20 | ||
| 141.58% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $90.00K | ||
| -$1.09 | ||
| -$731.00K | ||
| -812.22% | ||
| -$36.25M | ||
| -40.27% | ||
| -$33.89M | ||
| -37.65% | ||
| -$35.43M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.22 | ||
| 6.20 | ||
| 6.20 | ||
| - | ||
| - | ||
| -11.70 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 4.12 | ||
| 1.32 | ||
| 1.53 | ||
| 1.04 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $7.83M | ||
| $48.00M | ||
| $52.21M | ||
| $49.38M | ||
| $44.37M | ||
| $7.97M | ||
| $1.69M | ||
| $722.00K | ||
| $7.25M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $33.98M | ||
| $35.52M | ||
| $821.00K | ||
| $0.00 | ||
| $821.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$24.58M | ||
| -$104.00K | ||
| -$217.00K | ||
| $104.00K | ||
| -$24.68M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Stephens & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ATNM
FAQ
- What is the ticker symbol for Actinium Pharmaceuticals, Inc.?
- The ticker symbol for Actinium Pharmaceuticals, Inc. is NYSEAmerican:ATNM
- Does Actinium Pharmaceuticals, Inc. pay dividends?
- No, Actinium Pharmaceuticals, Inc. does not pay dividends
- What sector is Actinium Pharmaceuticals, Inc. in?
- Actinium Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Actinium Pharmaceuticals, Inc. in?
- Actinium Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is Actinium Pharmaceuticals, Inc. based in?
- Actinium Pharmaceuticals, Inc. is headquartered in United States
- When did Actinium Pharmaceuticals, Inc. go public?
- Actinium Pharmaceuticals, Inc. initial public offering (IPO) was on December 27, 2012
- Is Actinium Pharmaceuticals, Inc. in the S&P 500?
- No, Actinium Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Actinium Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Actinium Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Actinium Pharmaceuticals, Inc. in the Dow Jones?
- No, Actinium Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Actinium Pharmaceuticals, Inc. last earnings report?
- Actinium Pharmaceuticals, Inc.'s most recent earnings report was on May 15, 2025
- When does Actinium Pharmaceuticals, Inc. report earnings?
- The date for Actinium Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- ATNM Official Website www.actiniumpharma.com
- ATNM Profile on Yahoo Finance finance.yahoo.com/quote/ATNM
- ATNM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/atnm